|
Contact: Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com Colleen T. White Corporate Communications (201) 847-5369 Email: colleen_white@bd.com Franklin Lakes, NJ (August 30, 2005) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it would present at the Thomas Weisel Partners Healthcare Tailwinds Conference on Thursday, September 8, 2005 at 10:20 a.m. (ET). The live webcast of BD’s presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, September 15, 2005. BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products.For the fiscal year ended September 30, 2004, BD reported total revenues of $4.935 billion.
|